Anbex Awarded Bid from Hong Kong’s Department of Health
April 4, 2024
St. George-based Anbex has been awarded a bid from Hong Kong’s Department of Health for the supply of 187,040, 130mg IOSAT tablets. Anbex had previously won a similar-sized award from Hong Kong in 2021 on the supply of their potassium iodide tablets. Anbex is currently bidding on the supply of IOSAT tablets to Mexico, Argentina, Brazil, and Saudi Arabia. Anbex contracts with St. George-based Deseret Labs to manufacture the tablets.
For more information, visit anbex.com.
Recent News
- Biolexis Therapeutics Advances Breakthrough GLP-1 and AMPK Programs into First-in-Human Clinical Trials
- Rebel Medicine Announces Series A Financing and Investigational New Drug (IND) Application Opening to Advance Non‑Opioid Pain Therapeutic into Clinical Development
- NUSANO STABLE ISOTOPE PROGRAM ENRICHES GADOLINIUM-160 TO 99.2% PURITY
- CancerVax Targets Liver Cancers to Further Showcase Flexibility of Its Universal Platform
- Seek Labs Unveils BioSeeker™
- Halia Therapeutics Completes Enrollment in Phase 2a Clinical Trial of HT-6184 for Myelodysplastic Syndrome (MDS)
